Autologous CD133+ stem cell therapy (cell-based therapy for CABG)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous CD133+ stem cell therapy (cell-based therapy for CABG), covering 2017-10-18 to 2017-10-18. Get the full timeline:
Most recent: Clinical Trial Update: IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABG [NA]